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Abstract
Background: Most isolates of Pectobacterium carotovorum subsp. carotovorum (Pcc) produce bacteriocins. In this
study, we have determined that Pcc strain F-rif-18 has a chromosomal gene encoding the low-molecular-weight
bacteriocin, Carocin S2, and that this bacteriocin inhibits the growth of a closely related strain. Carocin S2 is
inducible by ultraviolet radiation but not by mutagenic agents such as mitomycin C.
Results: A carocin S2-defective mutant, TF1-2, was obtained by Tn5 insertional mutagenesis using F-rif-18. A
5706-bp DNA fragment was detected by Southern blotting, selected from a genomic DNA library, and cloned to
the vector, pMS2KI. Two adjacent complete open reading frames within pMS2KI were sequenced, characterized,
and identified as caroS2K and caroS2I, which respectively encode the killing protein and immunity protein. Notably,
carocin S2 could be expressed not only in the mutant TF1-2 but also in Escherichia coli DH5a after entry of the
plasmid pMS2KI. Furthermore, the C-terminal domain of CaroS2K was homologous to the nuclease domains of
colicin D and klebicin D. Moreover, SDS-PAGE analysis showed that the relative mass of CaroS2K was 85 kDa and
that of CaroS2I was 10 kDa.
Conclusion: This study shown that another nuclease type of bacteriocin was found in Pectobacterium carotovorum.
This new type of bacteriocin, Carocin S2, has the ribonuclease activity of CaroS2K and the immunity protein activity
of CaroS2I.
Background
The phytopathogenic enterobacterium, Pectobacterium
carotovorum subsp. carotovorum, is a phytoparasitic,
Gram-negative, facultative anaerobic bacterium [1]. Pcc
produces many extracellular pectic enzymes (pectate
lyase, pectin lyase, exopolygalacturnoate lyase) and
hydrolytic enzymes causing soft-rot disease, tissue
maceration, and cell wall collapse [2,3]. The only cur-
rent strategy against soft-rot disease involves chemical
agents that unavoidably contaminate the environment
[4]. Kikumoto et al. have demonstrated that mixed bac-
teriocin-producing avirulent strains of Pcc show high
efficacy against soft-rot disease of Chinese cabbage [5].
Bacteriocins are bactericidal, extracellular toxins,
produced by both Gram-positive and Gram-negative
bacteria [6,7]. These proteinaceous molecules kill closely
related bacteria. The susceptible cell is recognized by
specific target receptors on the membrane, and the pro-
ducer cell evades lethality by expressing a cognate
immune protein. The colicin family produced by Escher-
ichia coli is divided into DNase (colicins E2, E7, E8 and
E9), RNase (colicins E3, E4 and E6), tRNase (colicins
D and E5), and pore-forming colicins (colicins A, E1, Ia
and Ib) [8]. Bacteriocins (especially nuclease bacterio-
cins) have a high amino acid sequence homology.
Natural bacteriocin molecules act via a number of
mechanisms. For example, colicin E3 is a well-known
ribonuclease that specifically cleaves 16S rRNA at the
3’-end of the coding sequence both in vivo and in vitro,
which leads to the abolishment of protein synthesis
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any medium, provided the original work is properly cited.resulting in death of the susceptible cell [9-12]. Previous
reports indicate that colicin E3 consists of a killer protein
with three domains (i.e., a translocation domain [T
domain], receptor binding domain [R domain], and
nuclease domain) and an immunity protein that retards
antibiotic activity [13,14]. The R domain recognizes a speci-
fic receptor, BtuB on the cell membrane and the T domain
interacts with the TolB protein in the cell periplasm of the
sensitive cell to facilitate entry of the killer domain through
the cell membrane. In addition to the attack mechanism,
the immunity mechanism has been extensively elucidated.
Notably the immunity protein and the killer protein inter-
act initially at very high affinity because of charge attrac-
tion, and are separated at the cell surface through energy
generated from the proton motif force [15-17].
In general, the C-terminal domain determines the type
of bacteriocin. The C-terminal nuclease domains are not
only interchangeable but also lack species specificity
[18]. Strikingly, the tRNase type of bacteriocin may
accelerate exhaustion of tRNA in the cytoplasmic pool
and thereby impair protein synthesis in vivo.O g a w aet
al. have demonstrated that particular tRNA molecules
can be digested by colicin D as well as by colicin E5
[19,20]. It has been suggested that phage-associated kle-
bicin D is a tRNase type of bacteriocin based on similar-
ity to the nuclease-like domain of colicin D [21].
Nguyen et al. reported production of a high-molecular-
weight bacteriocin (carotovoricin Er) and Chuang et al.
reported production of a low-molecular-weight bacteriocin
(LMWB; carocin) by Pectobacterium[22,23]. The former
has a bulky antenna-like tail, inner core, and contractile
cylindrical structure, and the carotovoricin-caused inhibi-
tion zone can be easily distinguished from that of carocin
by its low diffusibility. Carocin S1 is a deoxyribonuclease
type of LMWB (indicated by the letter S) and is secreted
by Pcc strain 89-H-4. Additionally, export of Carocin S1
utilizes the type III secretion system in Pcc, which also
controls the cell motility of the bacterium [24].
Pcc strain F-rif-18 is a spontaneous rifampin-resistant
mutant of the wild-type 3F-3. Ultraviolet radiation can
induce Pcc strain F-rif-18 to produce the LMWB Caro-
cin S2. One of several sensitive cells, SP33, was selected
as an indicator strain here. In the present study, the
chromosomal bacteriocin gene, carocin S2,w a si n t r o -
duced into an expression plasmid encoding two pro-
teins, CaroS2K and CaroS2I. These proteins were
purified and characterized and their primary activities of
killing (CaroS2K) and immunity (CaroS2I) were investi-
gated in vivo and in vitro.
Results
Isolation of Transposon Insertion Mutants
Conjugation between F-rif-18 and E. coli 1830 resulted in
~3,500 colonies after selection on Modified Drigalski’s
agar medium containing rifampin and kanamycin. In
bacteriocin assay, the size of the inhibition zone around
each isolate was compared with that of F-rif-18. Mutant
colonies were identified by smaller inhibition zones. This
evidence of mutation suggested that transposon Tn5 had
been inserted into LMW bacteriocin-related genes. The
strain TF1-2, a putative insertion mutant, would no
longer produce LMW bacteriocin (Figure 1).
To ascertain whether Tn5 was actually introduced into
the genomic DNA of putative isolates, the nptII gene of
isolates was amplified using two primers P3 and P4 [23].
Southern blot technology showed that Tn5 had been
inserted (Additional file 1, Figure S1).
Identification of Tn5-inserted DNA Structures
To identify Tn5-interrupted genes, genomic DNA from
TF1-2 was amplified with TAIL-PCR using an array of
specific primers (Additional file 1, Figure S8). A 2621-bp
DNA fragment, including two open reading frames
(ORFs), was identified as the sequence containing the
bacteriocin structural gene. This gene was designated the
carocin S2 gene. To characterize the carocin S2 gene,
the TF1-2 probe was designed to hybridize in Southern
blots with a Bam HI-digested DNA fragment from the
genomic library of F-rif-18 (Figure 2A). A 5706-bp Bam
HI-digested DNA fragment (Figure 2B), harboring two
complete ORFs of carocin S2, was cloned into the plasmid
pMCL210 (Additional file 1, Figure S2). The carocin-
Figure 1 Bacteriocin assays of Tn5 insertion mutants of Pcc
strains. Strain number: 1, 3F3 (wild type); 2, 1830 (E. coli); 3, F-rif-18
(parent); 4, TF1-1 and 5, TF1-2 (insertion mutant). Other unlabelled
strains are Tn5 insertion mutants of F-rif-18 strain. The indicator is
Pcc strain SP33.
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con, comprising the predicted ORF2 of caroS2I,w a s
subcloned into the pGEM-T easy vector, resulting in the
plasmid pGS2I (Additional file 1, Figure S5).
Transcriptional analysis and in vivo expression of carocin
S2 gene
To determine whether the carocin S2 gene is transcribed
in a series of recombinant strains, reverse transcription-
Figure 2 DNA library screening and scheme of carocin S2 gene. (A) The TF1-2 probe was used to screen DNA fragments from the genomic
DNA library of F-rif-18. The DNA was digested with various restriction enzymes as follows: 1. Hpy188I; 2. HindIII; 3 HpaI; 4. EcoRV; 5. EcoRI; 6. ClaI;
7. BsaAI; 8. BglII; 9. BamHI; 10. AhdI; M. DNA leader marker; C. The TF1-2 probe DNA. The arrowhead indicates the 5.7-kb carocin S2 fragment. (B)
Shown is the 5.7-kb segment of DNA containing the carocin S2. The location of TF1-2 probe and part amplicon of cDNA of caroS2K and caroS2I
were shown.
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genic primers were designed to amplify parts of transcripts
from caroS2K or caroS2I, respectively (Figure 2B). Amplifi-
cation of parts of 16S ribosomal RNA transcripts indicated
that RNA in these bacterial cells is expressed at normal
levels (Figure 3).
The presence of the 925-bp amplicon revealed that
caroS2K was being transcribed in the cell (panel car-
oS2K in Figure 3). The TF1-2 strain, which is a Tn5
insertional mutant, could not transcribe caroS2K (lane 2),
but the ability of TF1-2 to transcribe caroS2K was
restored by introduction of pMS2KI (lane 3). It was
apparent that the amount of caroS2K expression was
dependent on the number of copies of plasmid pMS2KI
(compare lane 1 to lane 3). Additionally, carocin S2 can
be expressed in E. coli strain DH5a by introduction of
pMS2KI (lane 4 and lane 5).
T h ep r e s e n c eo fa2 5 9 - b pa m p l i c o ns h o w e dt h a t
caroS2I was transcribed constitutively (panel caroS2I in
Figure 3). The caroS2I gene was transcribed unexpect-
edly in mutant strain TF1-2 even though the plasmid
pMS2KI was introduced (lane 3). This demonstrated
that caroS2I is expressed constitutively regardless of
whether the gene caros2K is transcribed. Possibly an
individual promoter for caroS2I gene is located behind
the Tn5 insertion site in the caroS2K gene. CaroS2I
transcripts were detected in strain SP33 with plasmid
pGS2I (lanes 6 and 7). Although both the SP33 strains
(with or without pGEM T-easy) were susceptible to Car-
ocin S2, SP33/pGS2I appeared to grow in the presence
of CaroS2K (Figure 4B).
To prove that pMS2KI contained the gene for Carocin
S2, pMS2KI was introduced into TF1-2 and E. coli
DH5a. Both TF1-2/pMS2KI and DH5a/pMS2KI had
ability to express the activity of Carocin S2 (Figure 4A).
The size of inhibition zone around strain TF1-2/
pMS2KI was equal to that around DH5a/pMS2KI but
still smaller than that around the wild-type strain F-rif-18.
On the other hand, the quantity of transcripts expressed
in vivo and in vitrodid not usually correspond.
Deduction of the amino acid sequence of Carocin S2
The carocin S2 gene consists of two ORFs (Additional
file 1, Figure S7): one containing the 2352-bp caroS2K
gene and the other containing the 273-bp caroS2I gene.
The stop codon (TGA) of caroS2K overlaps the first
start codon of caroS2I by 4-bp (ATGA). The amino
sequences were deduced from the nucleotide sequence
Figure 3 Reverse Transcription PCR of RNA. Shown are cDNA from the following strains: Lanes 1, F-rif-18; 2, TF1-2; 3, TF1-2/pMS2KI, 4, DH5a;
5, DH5a/pMS2KI.; 6, SP33; 7, SP33/pGS2I. The amplicons of caroS2K and caroS2I are 925 bp and 259 bp, respectively. The corresponding
amplicons of 16S rRNA from the examined strains (lower panel). All samples were loaded equally.
Chan et al. BMC Microbiology 2011, 11:99
http://www.biomedcentral.com/1471-2180/11/99
Page 4 of 12of the carocin S2 gene using DNASIS-Mac software
(HITACHI, Japan) and compared to other analogous
proteins using the BLAST and FASTA search tools.
ORF1 was found to encode a 783-amino acid protein
with a high degree of homology to Pcc21 carocin D,
Escherichia coli colicin D and Klebsiella oxytoca klebicin D
(Figure 5); ORF2 was found to encode a 90-amino acid
protein that shows homology to the immunity proteins
of colicin D and klebicin D (Figure 5). Thus, caroS2K
produces an antibiotic with a deduced molecular mass of
85 kDa. CaroS2I (a 10-kDa protein of 90 amino acids)
was shown to confer resistance to CaroS2K. It is particu-
larly noteworthy that the homology between CaroS2K
and Colicin D and Klebicin D is at the C-terminal end of
these proteins where the catalytic center of a ribonu-
clease is located. According to the FASTA program, the
amino acid segment between Asp677 and the C-terminus
of CaroS2K shares almost 60% similarity with the
minimal tRNase domain of colicin D and klebicin D
( F i g u r e5 ) .S i n c et h ec o l i cin D and klebicin D are
well-known tRNase family of bacteriocins, suggests that
Carocin S2 might therefore be a ribonuclease.
Purification and characterization of Carocin S2
E. coli BL21 (DE3) recombinants, which were trans-
formed with pES2KI or pES2I, were used to express
CaroS2K protein or CaroS2I protein individually. Coo-
m a s s i eb l u es t a i n e dS D S - P A G Egels of purified Carocin
S2 are shown in Figure 6. The band corresponding to
CaroS2K was purified. The gel indicates a relative mass
(Mr) of about 85 kDa (Figure 6A), enrichment of the
purified CaroS2K (arrowhead), and disappearance of
other bands. Purification of CaroS2I by the same proce-
d u r er e s u l t e di nam o r ei n t e n s eb a n di nt h er e g i o no f
Mr 10 kDa (arrowhead; Figure 6B).
The purified CaroS2K involved in the growth inhibi-
tion of the susceptible indicator strain SP33 was then
characterized. The number of viable cells decreased with
increasing concentration of CaroS2K (Figure 7). Almost
all cells were dead at the initial concentration of 4 μg
ml
-1, indicating that about 90% of indicator strains are
killed at this concentration. However, the activity of
CaroS2K was inhibited by trypsin, but not inhibited by
CaroS2I.
Carocin S2 has ribonuclease activity
In order to confirm the role of carocin S2 as a ribonu-
clease type bacteriocin, we set up a RNA degradation
assay. Northern blots of 5’-
32P-labeled total RNA extract
treated with increasing concentrations of CaroS2K
(Figure 8B) showed a markedly lower intensity of labeled
RNA fragments compared to untreated extracted RNA
(Figure 8B, lane 1), suggesting that CaroS2K has ribonu-
clease activity.
Surprisingly the RNA segments were larger when the
RNA was 3’-
32P-labeled compared with 5’-
32P-labeling
(Figures 8B and 8C). As the concentrations of 23S
RNA and 16S RNA decrease on the addition of
increasing concentrations of CaroS2K, it is assumed
that more ribosomal RNA is degraded leaving material
that is ostensibly the ribosome. When excess concen-
trations of caroS2K (i.e 1 μg) are added then most of
the ribosomal RNA is degraded leading to a destabili-
zation and subsequent degradation of the ribosome
(Figure 8C, lane 2). We hence consider that CaroS2K
(in sufficient amount) would degrade the ribosome.
CaroS2I inhibits the killing activity of CaroS2K because
a mixture of equal quantities of CaroS2K and CaroS2I
prevented digestion of RNA segments by CaroS2K
(Figure 8C, lane 6).
Figure 4 Recovery and immunity activity of carocin S2.( A )
Antibacterial activity of carocin S2 from different strains. The
indicator was Pcc strain SP33. Strain number: 1, F-rif-18; 2, TF1-2; 3,
TF1-2/pMS2KI; 4, DH5a/pMS2KI; 5, DH5a. (B) Assay for caroS2I. The
colony and inoculated strains were F-rif-18. The indicator strains
were: 1, SP33; 2, SP33/pGEM-T easy; 3, SP33/pGS2I.
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indicator strain SP33 with the purified CaroS2K protein
had no effect on deoxyribonuclease activity, as com-
pared to the pattern of EcoRI-digested genomic DNA
(Figure 8A and Additional file 1, Figure S4).
Nucleotide sequence accession number
The Genbank accession number of the sequence of the
carocin S2 gene is HM475143.
Discussion
In this study, a chromosome-borne gene encoding bac-
teriocin, carocin S2, in Pcc strain 3F3 was shown to pos-
sess ribonuclease activity. According to Bradley’s
classification, Carocin S2 is a low-molecular-weight bac-
teriocin [25]. Two genes, caroS2K and caroS2I,e n c o d e
the 85-kDa and 10-kDa components, respectively, of
Carocin S2. The substrate and gene structure of carocin
S2 were unlike those of other bacteriocins from Pcc.
On the basis of sequence analysis, carocin S2 com-
prises these two overlapping ORFs, caroS2K and caroS2I
(Additional file 1, Figure S7). A putative Shine-Dalgarno
sequence 5’-AUGGA-3’, which has also been seen in the
DNA sequence of carocin S1, is located upstream (-9 bp
to -13 bp) of the start codon AUG, suggesting that it
could be a ribosome binding site for caroS2K [23]. Com-
parison of the upstream sequences of both caroS2K and
caroS2I has shown that the two consensus sequences,
5’-TATAAAAA-3’ (-34 bp to -41 bp) and 5’-GAAGT-3’
(-61 bp to -65 bp), are both upstream from the start
codon. Presumably, 5’-TATAAAAA-3’ is the -10 promo-
ter and 5’-GAAGT-3’ is the -35 promoter for the
Figure 5 Region similarity of the putative domains of carocin S2 with those of related bacteriocins. The related ORFs are shown.
Percentage values indicate the percent relatedness to the corresponding regions in carocin S2. The length of each domain is proportional to
the number of amino acids. Homologous domains are shaded similarly. Domain I is homologous with the N-terminal T domain of colicin E3 [27].
Domain II resembles the receptor binding domains of other bacteriocins, but has no significant homology to other sequences in the database
[8,30]. Domain III and ORF2 of carocin S2 are highly homologous to colicin D and klebicin D.
Figure 6 SDS-PAGE analysis of purified protein. Shown are the CaroS2K (A) and CaroS2I (B). Samples were subjected to electrophoresis in
10% polyacrylamide gels, which were stained with Coomassie blue. Lane M, molecular weight standards (kDa); lane 1, cell lysate of E. coli BL21/
pET32a; lane 4, cell lysate of BL21/pET30b; lanes 2 and 5, IPTG-induced cell lysates of BL21/pES2kI and BL21/pES2I, respectively; lanes 3 and 6,
purified protein obtained after elution. The arrowheads indicate the killing protein of carocin S2K (A) and the immunity protein of carocin S2I (B).
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E. coli[26].
A putative -10 promoter is 33 bp upstream from the
initiator ATG of the caroS2K gene, in which the SD
sequence is embedded, while the -35 promoter is 19 bp
upstream of the -10 promoter region. The putative pro-
moter of the -35 box of caroS2I is located similarly near
the -10 box, but the -10 box is just 24 bp upstream of
the start codon where no SD sequence is apparent.
Although those hypothesized promoters are located
within the caroS2K structural gene, transcripts of car-
oS2I are routinely produced (Figure 3). This suggests
that caroS2I RNA expression may be regulated posttran-
scriptionally, in spite of close neighboring genes down-
stream of the gene caroS2K; that is, core promoter
elements may influence the expression of caroS2I gene.
In the present study, we attempted to separate Car-
oS2K from CaroS2I attached to (His)6-tag using a Nickel
column (pEH2KI; Additional file 1, Figure S5), but a
small amount of CaroS2I (Mr ~10 kDa) was observed in
SDS-PAGE gels (Figure 6, bottom in lane 3), which had
little influence on the activity of CaroS2K as the purified
protein still had transient killing activity. Additionally,
the activity of the Carocin S2 complex at 4℃ was long-
lasting indicating good stability.
The C-terminal amino acid sequence of Carocin S2
had higher homology to those of colicin D and klebicin
D, which are produced by E. coli and Klebsiella oxytoca,
respectively, than to the amino acid sequence of carocin
S1 from the same species (Additional file 1, Figure S6B).
The amino acid sequence of CaroS2K has three puta-
tive domains. Domain I (the N-terminal 314-residue
sequence ending in Pro314) is regarded as the transloca-
tion domain and is homologous to the translocation
domains of carocin D and colicin E3 (Figure 5). It is
assumed to direct the cytotoxic domain to the periplas-
mic space [27,28]. Additionally, the putative TonB box
(a sequence recognition motif DTMTV) was found in
the N-terminal domain of CarocinS2, which is thought
to participate in bacteriocin translocation [8]. Thus, we
suggested that Carocin S2 could be a TonB-dependent
bacteriocin.
Domain III (extending from Asp677 to the carboxyl
terminus) is the killer domain. Particularly noteworthy is
the resemblance of the killer domain to the tRNase
domain of colicin D and klebicin D (Figure 5), and thus
we suggested that carocin S2 might have tRNase activity
[29-31]. Domain II extends 141 residues from Ilu315 to
Val455 and is hypothesized to be the binding site that
recognizes specific receptors on cell membranes. Addi-
tionally, domain III has no significant homology to caro-
cin D, suggesting that carocin S2 and carocin D have
different functions [28].
Finally, we showed that total RNA (whether labeled
with radioactive phosphate at the 5’-o ra tt h e3 ’-e n d )
is sensitive to Carocin S2. Carocin S2 degraded 5’-
labeled total RNA but not 5’-labeled CaroS2K-free RNA
(Figure 8B), and the amount of degradation was not
dose-dependent (arrowhead). However, the appearance
of segments of unknown origin paralleled partial degra-
dation of 23S and 16S rRNA (Figure 8C). These results
suggest that the site of excision (either conformational
or sequential) is close to the 5’-terminus of rRNA. Nota-
bly, the decrease in the amount of rRNA depended on
the amount of Carocin S2 protein present, with com-
plete degradation occurring in the presence of excess
Carocin S2. Ogawa et al. reported that RNase type of
bacteriocins, colicin E3 and colicin E5, catalyze the
hydrolysis of the shorter RNAs from 16S rRNA [19,32].
Moreover, colicin E5 was found to hydrolyze tRNA in
vitro. Furthermore, it was previously reported that coli-
cin E3 cleaved 16S rRNA completely, and even 30S
rRNA [11,33]. In our study, carocin S2 acted as an
RNase that hydrolyzes rRNA (both 23S and 16S) in
vitro. In terms of enzymatic function, Carocin S2 may
act as an endo- and exo-ribonuclease simultaneously.
Moreover, CaroS2I significantly inhibited nuclease activ-
ity in vitro but not in vivo (Figures 7, Figure 8 andAddi-
tional file 1, Figure S3). We speculated that immunity
protein CaroS2I might not be able to cross the cell
membrane, as previously described [14]. Although our
in vitro experiment showed that carocin S2 was a ribo-
nuclease, further investigation is needed to clarify its
function in cells.
One of the other Tn5 insertional mutants, TF1-1,
which disrupted the coding sequence of the fliC gene,
was found to halt expression of Carocin S2 (Figure 1),
indicating that Carocin S2 can also be secreted via the
type III secretion system [24]. The role of carocin S2 as
an RNase in the cytoplasm is to prevent protein synth-
esis by cleaving either 23S rRNA or 16S rRNA. The role
Figure 7 Survival of SP33 cells treated with Carocin S2. Aliquots
of indicator SP33 cells were treated with increasing concentrations
of CaroS2K (◆) and CaroS2K:CaroS2I in molar ratio of 1:1 (▲). The
effect of trypsin on the CaroS2K was also assayed (■). The data are
reported as means ± standard deviations.
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damage caused by CaroS2K in the cytoplasm. More
details of the actual mechanism of carocin S2 remain to
be elucidated.
Conclusion
As shown herein, the novel bacteriocin, Carocin S2, was
characterized as a ribonuclease. It is the first bacteriocin
with ribonuclease activity to be found in Pectobacterium
strains. We suggested that Carocin S2 kills the indicator
cell by exhausting its supply of some kinds of RNA,
leading to inactivation of protein biosynthesis. It will be
of interest to study the proteomics of Carocin S2 and its
mechanism of action in the future.
Methods
Bacterial strains, media, and growth conditions
Bacterial strains and plasmids used in the study are
listed in Table 1. Isolates of Pcc were grown at 28°C in
Luria-Bertani (LB) medium or IFO-802 medium. The
IFO-802 medium was supplemented with 1% polypeptin,
0.2% yeast extract, 0.1% MgSO4 (pH 7.0), and 1.5% agar.
Isolates of Pcc were distinguished from Escherichia coli
by their ability to grow on Modified Drigalski’sa g a r
Figure 8 In vitro hydrolysis of DNA and RNA by Carocin S2. (A)
Analysis of the DNase activity of carocin S2. Lane M, the HindIII-
digested l DNA marker; lane 1, genomic DNA only; lanes 2 and 3,
genomic DNA treated or untreated with carocin S2 in buffer,
respectively; lane 4, equal quantity of EcoRI-digested genomic DNA.
The 5’-labeled total RNA (B) and 3’-labeled total RNA (C) (1 μgo f
RNA per sample) were incubated without (lane 1) or with 1 μg
(lane 2), 100 ng (lane 3), 10 ng (lane 4), or 1 ng (lane 5) of Carocin
S2 and the result was assessed by autoradiography. The arrowhead
indicates that the RNA segment digested from ribosome. Equal
amounts of Carocin S2I and Carocin S2K mixed before RNA
digestion (lane 6).
Table 1 Bacteria and plasmids used in the study
Strain or plasmid Description Source
Escherichia coli
1830 pro¯ met¯ Kan
r Nm
r, containing
transposon Tn5 on the suicidal
plasmid pBJ4JI
[44]
DH5a supE44ΔlacU169(F80lacZΔM15)
hsdR17recA1 gyrA96thi-1relA1
[39]
BL21(DE3) hsdS gal(lcIts857 ind1 Sam7 nin5
lac UV5-T7 gene 1)
[45]
Pectobacterium
carotovorum subsp.
carotovorum
3F-3 Pcc, wild-type Laboratory
stock
F-rif-18 3F3, Rif
r, wild-type This study
TF1-1 F-rif-18, fliC::Tn5, Rif
r, Kan
r This study
TF 1-2 F-rif-18, CarocinS2::Tn5, Rif
r, Kan
r This study
SP33 Pcc, wild-type Laboratory
stock
Plasmid
pMCL210 p15A, Cml
r, Low copy number [46]
pGEM T-Easy Amp
r; lacZ cloning vector Promega
pET32a Amp
r; expression vector with the
N-terminal His-tag
Novagen
pET30b Kan
r; expression vector with the
C-terminal His-tag
Novagen
pMS2KI 5.7-kb BamHI DNA fragment
harboring carocin S2 gene from
3F3 genome, cloned into
pMCL210
This study
pEN2K* caroS2K subcloned into pET32a This study
pES2KI Derived from pEN2K; deleted
series of Tag element in front of
expressed caroS2K
This study
pEH2KI* Derived from pES2KI; adding
(His)6-Tag adjacent to caroS2I
This study
pGS2I caroS2I and its putative promoter
from pMS2KI, subcloned into
pGEM T-easy
This study
pECS2I* caroS2I subcloned into pET30b,
but the expressed fusion CaroS2I
has no activity
This study
pES2I Derived form pECS2I, the (His)6-
Tag element was deleted
This study
Kan
r: Kanamycin; Cml
r: Chloramphenicol; Rif
r: Rifampicin; Amp
r: Ampicillin.
*: See Additional file 1, Figure S5.
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ml
-1 of media) were added when necessary.
Bacterial conjugation
Overnight cultures of Pcc (recipient) and E. coli
(donor) were mixed and spread onto 0.22-μmm e m -
brane filters placed on LB agar media and incubated
overnight at 28°C [23]. The progeny after conjugation
were appropriately diluted and cultivated on Modified
Drigalski’s medium (with ampicillin and kanamycin
[100 μgm l
-1]) overnight at 28°C. All isolates were
placed on IFO-802 medium and tested for bacteriocins.
Bacteriocin was assayed using the double-layer method,
and Pcc SP33 was used as indicator strain [35]. The
cells were incubated for 12 hours to form colonies,
exposed to ultraviolet irradiation, incubated again for
12 hours, treated with chloroform to kill the cells, and
then covered with soft agar containing indicator cells.
The bacteriocin production was indicated by a zone of
inhibition of indicator-cell (SP33) growth around the
colony.
Genetic-engineering technique
The procedures of plasmid preparation, genomic DNA
isolation, and DNA manipulation were performed as
described by Sambrook et al. [36]. Oligonucleotide DNA
primers were synthesized by MD Bio Inc. (Taipei, Tai-
wan). The PCR was amplified with Go-Taq DNA poly-
merase (Promega, USA). The thermal asymmetric
interlaced PCR (TAIL-PCR) was performed as pre-
viously described [37].
Plasmids were introduced into Pcc strains using elec-
troporation (1.25 kV/cm, 200 Ω,2 5μF) [38]. For heat-
shock transformation, the competent cells of E. coli
were prepared according to the method of Hanahan
[39].
Exponentially growing cells (OD595 of about 6.0) were
harvested for RNA preparation. Total RNA was isolated
using Trizol reagent (Invitrogen, USA) according to the
manufacturer’s instructions. RNA was resuspended in
diethylpyrocarbonate (DEPC)-treated water. The con-
centration of RNA was determined by OD260 absorption,
and RNA was analyzed by electrophoresis on 1.5% for-
maldehyde-morpholinepropanesulfonic-agarose gel.
Reverse transcription-PCR (RT-PCR) was carried out
with AMV Reverse Transcriptase (Promega Inc., Tai-
wan) according to manufacturer’si n s t r u c t i o n s .R N A
(1 μg) was subjected to RT-PCR containing CaroS2_re_1
used as a reverse primer in first-strand cDNA synthesis.
The RT mixtures were diluted and used as templates in
a PCR reaction with two primers CaroS2_re_1 and
CaroS2_for_1 (Additional file 1, Table S1).
A 2621-bp BamHI-HindIII digested DNA fragment,
including the caroS2K and caroS2I genes, was amplified
from pMS2KI with primers of CarocinS2K_for2 and
CarocinS2I_rev2 (Additional file 1, Table S1) and
subcloned into pET32a to give the plasmid pEN2K
(Additional file 1, Figure S5). The pES2KI was obtained
by excision of the Tag element between the rbs (ribo-
some binding site) and start code (for CaroS2K) in
pEN2K using the SLIM method as previously described
[40,41]. The 5IHT32a2KI_forT, 5IHTGT2KI_forS,
5IHT32a3KI_revT, and 5IHT32a4KI_revS primers were
used. A 273-bp fragment of the caroS2I gene was ampli-
fied by PCR and ligated into the NdeIa n dXhoIs i t eo f
pET30b to form the plasmid pEC2I. Similarly, the plas-
mid pES2I was obtained by deleting the (His)6-tag of
pEC2I (carried out as described above with primers of
X21_forT, X21_forS, X21_revT and X21_revS). Subse-
quently, pES2KI and pES2I were introduced into E. coli
BL21 (DE3) cells, respectively.
Restriction DNA library screening and Southern blots
Southern blots were performed according to the DIG
Application Manual (Roche, USA). A 543-bp DNA frag-
ment (TF1-2 probe) was amplified with TF1-2P and
TF1-2A2 primers (Additional file 1, Table S1), sub-
cloned into pGEM-T Easy vector (Promega Inc., USA),
and labeled using a Random Primed DNA Labeling Kit
(Roche Diagnostics, USA).
The genomic DNA of the wild-type strain F-rif-18 was
digested with various restriction endonucleases, with
sites located outside the putative open reading frame.
Samples were electrophoresed and analyzed with South-
ern blotting. After detection using the TF1-2 probe, the
DNA from positive gel slices was purified and cloned
into pMCL210 to give the carocin-producing plasmid
pMS2KI. The pMS2KI construct was isolated and
detected as above with the TF1-2 probe.
Protein purification
The transformant cells of BL21, harboring pES2KI or
pES2I, were grown in 500 ml to an OD595 of 0.4. The
cells were induced with isopropyl-b-D-thiogalactopyra-
noside (IPTG; final concentration, 0.1 mM; at 25°C for 12
h). Subsequently, the cells were pelleted and the pellets
were sonicated (10 cycles of 9 s with 9-s intervals). BL21/
pES2KI pellets were subjected to ammonium sulfate preci-
pitation (30-40%), resuspended in buffer A (30 mM NaCl
and 20 mM Tris-Cl, pH 8.0), and applied to a Fractogel
column (Merck, USA). The fraction was eluted by a NaCl
gradient (30 mM-1.4 M). After purification through a
P-100 size-exclusion column (BioRad, USA), the CaroS2K
fractions were pooled and concentrated using an Amicon
centriprep-50 column (Millipore, USA) and dissolved
in buffer A. BL21/pES2I pellets were precipitated by
ammonium sulfate (70-100%) and resuspended in buffer
A. CaroS2I purification involved a similar
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3 column (Millipore, USA). The concentration of protein
was determined by the Bradford assay (Amresco, USA).
In vitro determination of Carocin S2 activity
Total RNA was treated with calf intestinal alkaline phos-
phatase (Promega, USA) at 55°C for 30 min as recom-
mended by the manufacturer. The reaction was arrested
by adding 5 mM nitrilotriacetic acid, and RNA was
extracted with equal volumes of phenol/chloroform. An
aliquot of phosphatase-treated RNA was 5’-
32P-labeled at
37°C for 30 min by incubation with a mixture of [g-
32P]
ATP, T4 polynucleotide kinase (Promega Inc, USA), and
reaction buffer in nuclease-free water [42]. [5’-
32P]Cytidine
3’,5’-bisphosphate (pCp) and T4 RNA ligase (Promega,
USA) were used for 3’-labeling of RNA [43]. Subsequently,
the mixture was purified by MicroSpin G-25 columns (GE
Healthcare, USA). The purified labeled RNA was divided
into aliquots and incubated without or with Carocin S2 at
28°C for 60 min, respectively. To measure its activity, Car-
oS2I was pre-mixed with an equal amount of CaroS2K.
The mixtures were subjected to electrophoresis on a 9%
polyacrylamide gel (19:1) containing 7M urea, 50 mM
Tris, 50 mM boric acid, and 1 mM EDTA, pH 8.3. All
samples were electrophoresed at 15℃ by PROTEIN II xi
(BioRad, USA).
To confirm DNase activity, 1 μg of genomic DNA
from SP33 in solution containing buffer A was incu-
bated with or without Carocin S2 at 28°C for 90 min.
An equal quantity of genomic DNA was digested with
EcoRI at 28°C for 90 min. Samples were then subjected
to electrophoresis on 1% agarose gel.
Antibiotic activity of Carocin S2
Overnight cultures of SP33 were diluted (1:100) with LB
medium and grown at 28°C to a density of approxi-
mately 10
5 CFU ml
-1. The activity of increasing concen-
trations of Carocin S2 on cells in suspension incubated
at 28°C for 60 min was assessed. CaroS2I was pre-mixed
with an equal molar ratio of CaroS2K. All reaction mix-
tures were spread onto LB agar plates and incubated at
28°C for 16 h. The experiment was performed three
times. Colonies growing on a series of plates were
respectively counted.
Computer analysis of sequence data
Sequencing of the DNA fragments was carried out using
an ABI automated DNA sequencer 373S. The nucleotide
sequence data were compiled by DNASIS-Mac software
(Hitachi, Japan). Amino acid sequences were compared
using international BLAST and FASTA servers. Also,
the putative domains of Carocin S2 were predicted
using the PSI/PHI-BLAST.
Additional material
Additional file 1: Figure S1. Analysis of Tn5 insertional mutants by
southern blotting. Lane M, the HindIII-digested l DNA marker; the
genomic DNA of strains were loading as follows: lane 1, TF1-2; lane 2, F-
rif-18; lane 3, 3F3; lane 4, TF1-1. Lane 5, the construct pGnptII that
contain the detect probe DNA nptII. The result shows that TF1-2 and
TF1-1 was a Tn5 insertional mutant. Figure S2. The construct pMS2KI
was cloned from genomic DNA library and screening by southern
blotting with TF1-2 probe. By southern blotting, it showed that the
carocin S2 has been cloned to form pMS2KI. Figure S3. The total RNA
of SP33 were digested with Carocin S2 and electrophoresis as
follows: lane 1, RNA (1 μg); lane 2, RNA and CaroS2K (20 μg); lane 3, RNA
and CaroS2I (4 μg); lanes 4 to 6 are RNA (1 μg) and CaroS2K (20 μg) with
gradient concentration of CaroS2I, which were added with 4 μg (lane 4);
20 μg (lane 5); 100 μg (lane 6). All reactions were performed at 28℃ for
3 hours. Figure S4. Metal effect of In vitro hydrolysis of DNA by
Carocin S2. Lane M, the HindIII-digested l DNA marker; lane 1, the
genomic DNA of SP33 only; lane 2, the EcoRI-digested genomic DNA; the
genomic DNA was incubated with Carocin S2 (lane 3 to 5), or not.
Magnesium acetate, nickel acetate and zinc acetate was added in buffer
A (pH = 7), respectively. The reactions were performed at performed at
28℃ for 1 hour. Figure S5. Schematic representation of the cloning
strategy used in this study. (1) A 543-bp amplicon was cloned into the
vector pTF1 to form the pTF1-2-probe. (2) The TF1-2 probe was
prepared. (3) The multi-enzyme-digested DNA fragments were obtained
from F-rif-18 genomic DNA, and they were detected on southern blots.
(4) Positive cDNA was cloned into the carocin-producing plasmid
pMS2KI. (5) A 2621-bp amplicon, from pMS2KI, was subcloned into
pET32a to form pEN2K. (6) The 5’-transcriptional element, which would
be translated into the Flag tag, was deleted from pEN2K using the SLIM
method [40]. (7) By using SLIM method, an element encoding a stretch
of six histidines was inserted into caroS2I to form pEH2KI. (8) A 484-bp
amplicon was subcloned into pGEM T-easy vector to form pGS2I. (9)
A273-bp fragment of the caroS2I gene was amplified from pGS2I and
subcloned into pET30b to form pECS2I. (10) The 3’-transcriptional
element, which would be translated to (His)6-Flag, was deleted from
pES2I using the SLIM method. Figure S6. Alignment of the deduced
amino acid sequences of carocin S2 with those of homologous
domains of bacteriocins. The potential TonB-binding motif is shown by
red underline. (A) The N-terminal translocation domain of CaroS2K (Met1
to Pro314) has homology to carocin D and colicin E3. (B) The killing
domain of CaroS2K (Asp677 to carboxyl terminus) has homology to the
minimal tRNase domain of colicin D and klebicin D. (C) The deduced
amino acid of immunity protein of CaroS2I has homology to colicin D
and klebicin D. Figure S7. The gene and deduced amino acid
sequence of carocin S2 shows in the study. The sequence was
truncated form pMS2KI. The underline shows the putative promoter.
Figure S8. Schematic representation of thermal asymmetric
interlaced PCR (TAIL-PCR) were manipulated according to the method
of Liu and Whittier, but the annealing temperature was decreased from
63℃ to 60℃ for specific primers [37,23]. Amplifying the unknown DNA
fragment are the specific primers which are complementary to the
known sequence (Tn5) and the arbitrary degenerate primers which could
be complementary to the opposite unknown site. The specific primers
(SP) are PR1, PR2, PR3, PF1, PF2, PF3, and TF1-2S1 to TF1-2A6 primers for
opposite direction (Additional file 1, Table S1). In addition, the arbitrary
degenerate primers (AD) N1, N2, and N3 were respectively used as
simultaneous PCR amplification (see above).
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